Senior Manager, Clinical Risk Management
ICON plc
Summary
At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON's global expertise. As a Senior Manager, Clinical Risk Management at ICON, you will be crucial in identifying, assessing, and mitigating risks associated with clinical trials.
Job description
What You Will Do
You will oversee scientific operations, balancing quality, timelines, and stakeholder expectations.
Key responsibilities include
- Review study, site and participant level data and risk indicators.
- Identify trends, anomalies and emerging quality or compliance risks.
- Document findings and coordinate follow up with monitoring and study teams.
- Support risk assessment and monitoring strategy updates.
- Maintain clear evidence of review, decisions and actions.
- Set clear priorities and performance expectations for assigned staff or workstreams and develop capability through coaching and feedback.
- Monitor delivery, quality, capacity and risks across the assigned scope and ensure timely escalation and corrective action.
Required qualifications and experience
- Degree in Life Sciences, Medicine, Risk Management, or a related field.
- Extensive experience in clinical risk management or related roles, with a strong background in assessing and mitigating risks in clinical trials.
- Proven leadership skills, with experience managing and developing a team focused on risk management and patient safety.
- Expertise in regulatory requirements, industry standards, and risk management methodologies, with a solid understanding of clinical trial operations.
- Clinical research or life sciences experience with a sound understanding of trial conduct.
- Knowledge of ICH Good Clinical Practice (GCP) and risk based quality management principles.
- Experience with clinical systems such as electronic data capture (EDC), clinical trial management systems (CTMS) or central monitoring tools.
- Experience reviewing study, site and participant level data and risk indicators.
Preferred qualifications and experience
- Prior central monitoring or risk based monitoring experience.
- Experience with subject level data review or monitoring analytics.
Requirements
- Degree in Life Sciences, Medicine, Risk Management, or a related field
- Extensive experience in clinical risk management or related roles
- Strong background in assessing and mitigating risks in clinical trials
- Proven leadership skills managing and developing a team focused on risk management and patient safety
- Expertise in regulatory requirements, industry standards, and risk management methodologies
- Solid understanding of clinical trial operations
- Clinical research or life sciences experience with sound understanding of trial conduct
- Knowledge of ICH Good Clinical Practice (GCP) and risk based quality management principles
- Experience with clinical systems such as EDC, CTMS or central monitoring tools
- Experience reviewing study, site and participant level data and risk indicators
- Prior central monitoring or risk based monitoring experience
- Experience with subject level data review or monitoring analytics
Benefits
- Competitive base salary
- Performance incentives
- Medical, Dental & Vision
- Retirement plans
- Pension plans
- Life assurance
- Disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.